Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
-71.31%
Shrank
—
—
Shrank
—
1 Year
Score—
Net Growth-71.31%
Net TrendShrank
Net Income Consistency—
Rev Growth—
Rev TrendShrank
Revenue Consistency—
5 Years
2.0
-126.47%
40%
—
-100.00%
Never
—
5 Years
Score2.0
Net Growth-126.47%
Net Trend40%
Net Income Consistency—
Rev Growth-100.00%
Rev TrendNever
Revenue Consistency—
Eledon Pharmaceuticals Inc fundamental performance
Between 2020 and 2025, revenue declined from $ 120K to $ 0.00 and net income went from -$ 22M to -$ 45M. Revenue increased in 0 of those 5 years; net income in 2.
Eledon Pharmaceuticals Inc currently holds a 5-year HDB Score of 2.0 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 3.77 | — |
1 Year2025-08-12 | $ 2.66 | 41.73% |
5 Years2021-08-12 | $ 6.30 | -40.16% |
10 Years2016-08-12 | $ 184.68 | -97.96% |
All Time2014-09-17 | $ 3.85K | -99.90% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | All Time2014-09-17 |
|---|---|---|---|---|---|
| Price | $ 3.77 | $ 2.66 | $ 6.30 | $ 184.68 | $ 3.85K |
| Return | — | 41.73% | -40.16% | -97.96% | -99.90% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 0.00 | -$ 78M | $ 111M |
| 2025 | $ 0.00 | -$ 45M | $ 133M |
| 2024 | $ 0.00 | -$ 36M | $ 140M |
| 2023 | $ 0.00 | -$ 40M | $ 51M |
| 2022 | $ 0.00 | -$ 87M | $ 56M |
| 2021 | $ 120K | -$ 34M | $ 84M |
| 2020 | $ 120K | -$ 22M | $ 114M |
| 2019 | $ 0.00 | -$ 16M | $ 8M |
| 2018 | $ 0.00 | -$ 14M | $ 12M |
| 2017 | $ 0.00 | -$ 13M | $ 17M |
| 2016 | -$ 37M | $ 27M | |
| 2015 | -$ 45M | $ 63M | |
| IPO2014 | -$ 23M | $ 105M | |
| 2013 | -$ 15M | $ 31M | |
| 2012 | -$ 9M | $ 11M |
Explore beyond ELDN
You're looking at Eledon Pharmaceuticals Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
